Socio-economic demands and challenges for non-invasive disease diagnosis through a portable breathalyzer by the incorporation of 2D nanosheets and SMO nanocomposites

Breath analysis for non-invasive clinical diagnostics and treatment progression has penetrated the research community owing to the technological developments in novel sensing nanomaterials.

Download Full-text

Non-invasive disease diagnosis using surface-enhanced Raman spectroscopy of urine and saliva

Applied Spectroscopy Reviews ◽

10.1080/05704928.2018.1562938 ◽

2019 ◽

Vol 55 (3) ◽

pp. 197-219 ◽

Cited By ~ 3

Author(s):

Lingwei Ma ◽

Zhengjun Zhang ◽

Xiaogang Li

Keyword(s):

Raman Spectroscopy ◽

Disease Diagnosis ◽

Surface Enhanced Raman Spectroscopy ◽

Invasive Disease ◽

Non Invasive ◽

Surface Enhanced ◽

Surface Enhanced Raman

Download Full-text

Advanced Biomimetic Nanomaterials for Non-invasive Disease Diagnosis

Frontiers in Materials ◽

10.3389/fmats.2021.664795 ◽

2021 ◽

Vol 8 ◽

Author(s):

Zhiyuan Feng ◽

Hao Fan ◽

Lin Cheng ◽

Huan Zhang ◽

Hong Fan ◽

...

Keyword(s):

Social Stress ◽

Large Scale ◽

Metabolic Diseases ◽

Disease Diagnosis ◽

Invasive Disease ◽

Non Invasive ◽

Disease Marker ◽

Medical Materials ◽

Biomimetic Nanomaterials ◽

Marker Detection

In modern society, the incidence of cancer, inflammatory diseases, nervous system diseases, metabolic diseases, and cardiovascular diseases is on the rise. These diseases not only cause physical and mental suffering for patients, but also place an enormous burden on society. Early, non-invasive diagnosis of these diseases can reduce the physical and mental pain of patients and social stress. There is an urgent need for advanced materials and methods for non-invasive disease marker detection, large-scale disease screening, and early diagnosis. Biomimetic medical materials are synthetic materials designed to be biocompatible or biodegradable, then developed for use in the medical industry. In recent years, with the development of nanotechnology, a variety of biomimetic medical materials with advanced properties have been introduced. Biomimetic nanomaterials have made great progress in biosensing, bioimaging, and other fields. The latest advance of biomimetic nanomaterials in disease diagnosis has attracted tremendous interest. However, the application of biomimetic nanomaterials in disease diagnosis has not been reviewed. This review particularly focuses on the potential of biomimetic nanomaterials in non-invasive disease marker detection and disease diagnosis. The first part focuses on the properties and characteristics of different kinds of advanced biomimetic nanomaterials. In the second part, the recent cutting-edge methods using biosensors and bioimaging based on biomimetic nanomaterials for non-invasive disease diagnosis are reviewed. In addition, the existing problems and future development of biomimetic nanomaterials is briefly described in the third part. The application of biomimetic nanomaterials would provide a novel and promising diagnostic method for non-invasive disease marker detection, large-scale clinical screening, and diagnosis, promoting the exploitation of devices with better detection performance and the development of global clinical public health.

Download Full-text

Cutting Edge Methods for Non-Invasive Disease Diagnosis Using E-Tongue and E-Nose Devices

Biosensors ◽

10.3390/bios7040059 ◽

2017 ◽

Vol 7 (4) ◽

pp. 59 ◽

Cited By ~ 14

Author(s):

Jessica Fitzgerald ◽

Hicham Fenniri

Keyword(s):

Disease Diagnosis ◽

Invasive Disease ◽

Cutting Edge ◽

Non Invasive

Download Full-text

A phylogeny-free microbiome dysbiosis detection pipeline for non-invasive disease diagnosis

2017 IEEE International Conference on Electro Information Technology (EIT) ◽

10.1109/eit.2017.8053343 ◽

2017 ◽

Author(s):

O. Ufuk Nalbantoglu ◽

A. Emre Onuk

Keyword(s):

Disease Diagnosis ◽

Invasive Disease ◽

Non Invasive

Download Full-text

Breath Analysis as a Potential and Non-Invasive Frontier in Disease Diagnosis: An Overview

Metabolites ◽

10.3390/metabo5010003 ◽

2015 ◽

Vol 5 (1) ◽

pp. 3-55 ◽

Cited By ~ 111

Author(s):

Jorge Pereira ◽

Priscilla Porto-Figueira ◽

Carina Cavaco ◽

Khushman Taunk ◽

Srikanth Rapole ◽

...

Keyword(s):

Breath Analysis ◽

Disease Diagnosis ◽

Non Invasive

Download Full-text

CURRENT APPROACH ON CUTANEOUS MELANOMA DIAGNOSTICS

Problems in oncology ◽

10.37469/0507-3758-2019-65-5-638-644 ◽

2019 ◽

Vol 65 (5) ◽

pp. 638-644

Author(s):

Mariya Ebert ◽

Georgiy Gafton ◽

Grigoriy Zinovev ◽

I. Gafton

Keyword(s):

Physical Examination ◽

Cutaneous Melanoma ◽

Growth Dynamics ◽

Current Approach ◽

Clinical Diagnostics ◽

Skin Tumors ◽

Steady Increase ◽

Non Invasive ◽

Early Stages ◽

Other Information

Melanoma is on the first place in mortality among all skin tumors. Over the past 50 years, there has been a steady increase in the incidence of cutaneous melanoma compared to other types of tumors. Rates of 5-year survival are fairly high, if melanoma is diagnosed in the early stages, which requires adequate diagnostics and treatment. Melanoma diagnostic, especially in the early stages, can be problematic even for an experienced dermatologist. However, primary contact doctor can be any specialty. Melanoma and other skin tumors can be detected by physical examination during treatment for another disease. Phenotypic risks factors, anamnestic data, and physical examination data are important in cutaneous melanoma diagnostics. The sensitivity of clinical diagnosis during a visual examination by an experienced dermatologist is approximately 70 percent. However, dermascopy can significantly increase the accuracy of a clinical diagnostics. In recent years there has been an active research for new non-invasive methods and algorithms for cutaneous melanoma diagnostics. The main goal of non-invasive diagnostics is to determine need for biopsy. This decision should be based on a combination of clinical and dermascopic examinations and other information, including growth dynamics, symptoms and medical history. Thus, an adequate diagnostic of cutaneous melanoma, including non-invasive and invasive methods, is a simple and economically viable way to early detection of cutaneous melanoma and to reduce mortality from this aggressive disease.

Download Full-text

Non-invasive diagnostics in fossils - Magnetic Resonance Imaging of pathological belemnites

Biogeosciences ◽

10.5194/bg-2-133-2005 ◽

2005 ◽

Vol 2 (2) ◽

pp. 133-140 ◽

Cited By ~ 18

Author(s):

D. Mietchen ◽

H. Keupp ◽

B. Manz ◽

F. Volke

Keyword(s):

Magnetic Resonance Imaging ◽

Magnetic Resonance ◽

Soft Tissue ◽

Clinical Diagnostics ◽

Resonance Imaging ◽

Non Invasive ◽

Physiological Processes ◽

Magnetic Resonance Imaging Mri ◽

Invasive Diagnostics

Abstract. For more than a decade, Magnetic Resonance Imaging (MRI) has been routinely employed in clinical diagnostics because it allows non-invasive studies of anatomical structures and physiological processes in vivo and to differentiate between healthy and pathological states, particularly of soft tissue. Here, we demonstrate that MRI can likewise be applied to fossilized biological samples and help in elucidating paleopathological and paleoecological questions: Five anomalous guards of Jurassic and Cretaceous belemnites are presented along with putative paleopathological diagnoses directly derived from 3D MR images with microscopic resolution. Syn vivo deformities of both the mineralized internal rostrum and the surrounding former soft tissue can be traced back in part to traumatic events of predator-prey-interactions, and partly to parasitism. Besides, evidence is presented that the frequently observed anomalous apical collar might be indicative of an inflammatory disease. These findings highlight the potential of Magnetic Resonance techniques for further paleontological applications.

Download Full-text

Next-Generation Biomarkers for Cholangiocarcinoma

Cancers ◽

10.3390/cancers13133222 ◽

2021 ◽

Vol 13 (13) ◽

pp. 3222

Author(s):

Pedro M. Rodrigues ◽

Arndt Vogel ◽

Marco Arrese ◽

Domingo C. Balderramo ◽

Juan W. Valle ◽

...

Keyword(s):

Biomarker Discovery ◽

Tumor Development ◽

Predictive Biomarkers ◽

Disease Diagnosis ◽

Future Research ◽

Tumor Biopsy ◽

Non Invasive ◽

Tumor Stages ◽

At Risk Populations ◽

Early Tumor

The increasing mortality rates of cholangiocarcinoma (CCA) registered during the last decades are, at least in part, a result of the lack of accurate non-invasive biomarkers for early disease diagnosis, making the identification of patients who might benefit from potentially curative approaches (i.e., surgery) extremely challenging. The obscure CCA pathogenesis and associated etiological factors, as well as the lack of symptoms in patients with early tumor stages, highly compromises CCA identification and to predict tumor development in at-risk populations. Currently, CCA diagnosis is accomplished by the combination of clinical/biochemical features, radiological imaging and non-specific serum tumor biomarkers, although a tumor biopsy is still needed to confirm disease diagnosis. Furthermore, prognostic and predictive biomarkers are still lacking and urgently needed. During the recent years, high-throughput omics-based approaches have identified novel circulating biomarkers (diagnostic and prognostic) that might be included in large, international validation studies in the near future. In this review, we summarize and discuss the most recent advances in the field of biomarker discovery in CCA, providing new insights and future research directions.

Download Full-text

Virus induced hepatocellular carcinoma (HCC) and protein biomarkers

Pakistan BioMedical Journal ◽

10.52229/pbmj.v4i2.72 ◽

2021 ◽

Author(s):

Hamza Abbas Jaffari ◽

Sumaira Mazhar

Keyword(s):

Hepatocellular Carcinoma ◽

Early Stage ◽

Imaging Techniques ◽

Disease Diagnosis ◽

Protein Biomarkers ◽

Early Disease ◽

Detection Systems ◽

Non Invasive ◽

Viral Hepatitis B ◽

Current Article

Hepatocellular carcinoma (HCC) is a standout amongst the most widely recognized cancers around the world, and just as the alcoholic liver disease it is also progressed by extreme viral hepatitis B or C. At the early stage of the disease, numerous patients are asymptomatic consequently late diagnosis of HCC occurs resulting in expensive surgical resection or transplantation. On the basis of the alpha fetoprotein (AFP) estimation, combined with the ultrasound and other sensitive imaging techniques used, the non-invasive detection systems are available. For early disease diagnosis and its use in the effective treatment of HCC patients, the identification of HCC biomarkers has provided a breakthrough utilizing the molecular genetics and proteomics. In the current article, most recent reports on the protein biomarkers of HBV or HCV-related HCC and their co-evolutionary association with liver cancer are reviewed.

Download Full-text